$NAVB: Navidea Biopharmaceuticals Announces Patent Extension for …

Date: Friday, December 7th, 2018

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the …

Full article address: https://www.businesswire.com/news/home/20181207005042/en/Navidea-Biopharmaceuticals-Announces-Patent-Extension-Lymphoseek%C2%AE

Related News:

$NAVB: Navidea Biopharmaceuticals Appoints Adam Cutler to Board of …

$NAVB: Navidea Biopharmaceuticals Appoints Dr. Michael Rosol as Chief …

$NAVB: Navidea Biopharmaceuticals to Present at the 11

$NAVB: Navidea Biopharmaceuticals Announces Presentation at the …

$NAVB: Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of …

$NAVB: Navidea Biopharmaceuticals Reports Third Quarter 2018 Financial …

$NAVB: Navidea Biopharmaceuticals Wins Dismissal of Platinum Litigation

$NAVB: Navidea Biopharmaceuticals Receives Acceptance Letter from …

$NAVB: Navidea Biopharmaceuticals to Present Data on the Manocept …

$NAVB: Navidea Biopharmaceuticals to Present at the 2018 BIO Investor …

$NAVB $TLRY: 60 Biggest Movers From Yesterday

Latest News:

$INFY: Running Multiple Digital Initiatives at Scale is What Sets Visionary …

$JBLU $LUV $DAL $UAL: JetBlue Still Trading At 10% Discount After Stellar December Traffic …

$GPRE $ADM $VLO: Is Green Plains a Buy?

$XNET: Wonderful Review of Innovative Technology at China Tech First …

$MMC: Financial Institutions Can Out-Innovate Fintechs Through Greenfield …

$SRE: SoCalGas Issues “Dial It Down” Alert Through Thursday Morning

$AFL: Is It Time To Buy Aflac Ahead Of Their Anticipated Dividend Increase?

$HYMTF $SSNLF: Korea’s Fourth Quarter GDP Growth Beats Expectations

$FM: iShares MSCI Frontier 100 ETF: Exposure To Smaller And Riskier …

$LOGI: Logitech Delivers Record Q3 Sales, Raises Full-Year Profit Outlook

$GORO: Gold Resource Corporation Achieves 2018 Annual Gold and Silver …